O	0	5	Roles	Role	NNS	B-NP
O	6	8	of	of	IN	B-PP
O	9	14	brca2	brca2	NN	B-NP
O	15	16	(	(	(	O
O	16	22	fancd1	fancd1	NN	B-NP
O	22	23	)	)	)	O
O	24	26	in	in	IN	B-PP
B-Cellular_component	27	33	oocyte	oocyte	NN	B-NP
I-Cellular_component	34	41	nuclear	nuclear	JJ	I-NP
O	42	54	architecture	architecture	NN	I-NP
O	54	55	,	,	,	O
O	56	69	gametogenesis	gametogenesis	NN	B-NP
O	69	70	,	,	,	O
B-Cancer	71	76	gonad	gonad	JJ	B-NP
I-Cancer	77	83	tumors	tumor	NNS	I-NP
O	83	84	,	,	,	O
O	85	88	and	and	CC	O
O	89	95	genome	genome	NN	B-NP
O	96	105	stability	stability	NN	I-NP
O	106	108	in	in	IN	B-PP
O	109	118	zebrafish	zebrafish	NN	B-NP
O	118	119	.	.	.	O

O	121	125	Mild	Mild	JJ	B-NP
O	126	135	mutations	mutation	NNS	I-NP
O	136	138	in	in	IN	B-PP
O	139	144	BRCA2	BRCA2	NN	B-NP
O	145	146	(	(	(	O
O	146	152	FANCD1	FANCD1	NN	B-NP
O	152	153	)	)	)	O
O	154	159	cause	cause	VBP	B-VP
O	160	167	Fanconi	Fanconi	NN	B-NP
O	168	174	anemia	anemia	NN	I-NP
O	175	176	(	(	(	O
O	176	178	FA	FA	NN	B-NP
O	178	179	)	)	)	O
O	180	184	when	when	WRB	B-ADVP
O	185	195	homozygous	homozygous	JJ	O
O	195	196	,	,	,	O
O	197	202	while	while	IN	B-SBAR
O	203	209	severe	severe	JJ	B-NP
O	210	219	mutations	mutation	NNS	I-NP
O	220	225	cause	cause	VBP	B-VP
O	226	232	common	common	JJ	B-NP
B-Cancer	233	240	cancers	cancer	NNS	I-NP
O	241	250	including	include	VBG	B-PP
B-Cancer	251	257	breast	breast	NN	B-NP
O	257	258	,	,	,	O
B-Cancer	259	266	ovarian	ovarian	JJ	B-ADJP
O	266	267	,	,	,	O
O	268	271	and	and	CC	O
B-Cancer	272	280	prostate	prostate	NN	B-NP
I-Cancer	281	288	cancers	cancer	NNS	I-NP
O	289	293	when	when	WRB	B-ADVP
O	294	306	heterozygous	heterozygous	JJ	B-ADJP
O	306	307	.	.	.	O

O	308	312	Here	Here	RB	B-ADVP
O	313	315	we	we	PRP	B-NP
O	316	322	report	report	VBP	B-VP
O	323	324	a	a	DT	B-NP
O	325	334	zebrafish	zebrafish	NN	I-NP
O	335	340	brca2	brca2	NN	I-NP
O	341	352	insertional	insertional	JJ	I-NP
O	353	359	mutant	mutant	NN	I-NP
O	360	364	that	that	WDT	B-NP
O	365	371	shares	share	VBZ	B-VP
O	372	382	phenotypes	phenotype	NNS	B-NP
O	383	387	with	with	IN	B-PP
O	388	393	human	human	JJ	B-NP
O	394	402	patients	patient	NNS	I-NP
O	403	406	and	and	CC	O
O	407	417	identifies	identify	VBZ	B-VP
O	418	419	a	a	DT	B-NP
O	420	425	novel	novel	JJ	I-NP
O	426	431	brca2	brca2	NN	I-NP
O	432	440	function	function	NN	I-NP
O	441	443	in	in	IN	B-PP
O	444	453	oogenesis	oogenesis	NN	B-NP
O	453	454	.	.	.	O

O	455	466	Experiments	Experiment	NNS	B-NP
O	467	473	showed	show	VBD	B-VP
O	474	478	that	that	IN	B-SBAR
B-Developing_anatomical_structure	479	485	mutant	mutant	JJ	B-NP
I-Developing_anatomical_structure	486	493	embryos	embryo	NNS	I-NP
O	494	497	and	and	CC	O
B-Cell	498	504	mutant	mutant	JJ	B-NP
I-Cell	505	510	cells	cell	NNS	I-NP
O	511	513	in	in	IN	B-PP
O	514	521	culture	culture	NN	B-NP
O	522	533	experienced	experience	VBD	B-VP
O	534	540	genome	genome	NN	B-NP
O	541	552	instability	instability	NN	I-NP
O	552	553	,	,	,	O
O	554	556	as	as	IN	B-SBAR
O	557	559	do	do	VBP	O
B-Cell	560	565	cells	cell	NNS	B-NP
O	566	568	in	in	IN	B-PP
O	569	571	FA	FA	NN	B-NP
O	572	580	patients	patient	NNS	I-NP
O	580	581	.	.	.	O

O	582	584	In	In	IN	B-PP
O	585	589	wild	wild	JJ	B-NP
O	589	590	-	-	HYPH	I-NP
O	590	594	type	type	NN	I-NP
O	595	604	zebrafish	zebrafish	NN	I-NP
O	604	605	,	,	,	O
O	606	613	meiotic	meiotic	JJ	B-NP
B-Cell	614	619	cells	cell	NNS	I-NP
O	620	629	expressed	express	VBD	B-VP
O	630	635	brca2	brca2	NN	B-NP
O	635	636	;	;	:	O
O	637	640	and	and	CC	O
O	640	641	,	,	,	O
O	642	654	unexpectedly	unexpectedly	RB	B-ADVP
O	654	655	,	,	,	O
O	656	667	transcripts	transcript	NNS	B-NP
O	668	670	in	in	IN	B-PP
B-Cell	671	678	oocytes	oocyte	NNS	B-NP
O	679	688	localized	localize	VBN	B-VP
O	689	703	asymmetrically	asymmetrically	RB	B-ADVP
O	704	706	to	to	TO	B-PP
O	707	710	the	the	DT	B-NP
B-Cellular_component	711	717	animal	animal	NN	I-NP
I-Cellular_component	718	722	pole	pole	NN	I-NP
O	722	723	.	.	.	O

O	724	726	In	In	IN	B-PP
O	727	735	juvenile	juvenile	JJ	B-NP
O	736	741	brca2	brca2	NN	I-NP
O	742	749	mutants	mutant	NNS	I-NP
O	749	750	,	,	,	O
B-Cell	751	758	oocytes	oocyte	NNS	B-NP
O	759	765	failed	fail	VBD	B-VP
O	766	768	to	to	TO	I-VP
O	769	777	progress	progress	VB	I-VP
O	778	785	through	through	IN	B-PP
O	786	793	meiosis	meiosis	NN	B-NP
O	793	794	,	,	,	O
O	795	802	leading	lead	VBG	B-VP
O	803	805	to	to	TO	B-PP
O	806	812	female	female	JJ	B-NP
O	812	813	-	-	HYPH	I-NP
O	813	815	to	to	TO	B-PP
O	815	816	-	-	HYPH	B-NP
O	816	820	male	male	JJ	I-NP
O	821	824	sex	sex	NN	I-NP
O	825	833	reversal	reversal	NN	I-NP
O	833	834	.	.	.	O

O	835	840	Adult	Adult	JJ	B-NP
O	841	848	mutants	mutant	NNS	I-NP
O	849	855	became	become	VBD	B-VP
O	856	863	sterile	sterile	JJ	B-NP
O	864	869	males	male	NNS	I-NP
O	870	873	due	due	JJ	B-ADJP
O	874	876	to	to	TO	B-PP
O	877	880	the	the	DT	B-NP
O	881	888	meiotic	meiotic	JJ	I-NP
O	889	895	arrest	arrest	NN	I-NP
O	896	898	of	of	IN	B-PP
B-Cell	899	912	spermatocytes	spermatocyte	NNS	B-NP
O	912	913	,	,	,	O
O	914	919	which	which	WDT	B-NP
O	920	924	then	then	RB	B-ADVP
O	925	929	died	die	VBD	B-VP
O	930	932	by	by	IN	B-PP
O	933	942	apoptosis	apoptosis	NN	B-NP
O	942	943	,	,	,	O
O	944	952	followed	follow	VBN	B-VP
O	953	955	by	by	IN	B-PP
B-Cancer	956	966	neoplastic	neoplastic	JJ	B-NP
O	967	980	proliferation	proliferation	NN	I-NP
O	981	983	of	of	IN	B-PP
B-Cell	984	989	gonad	gonad	JJ	B-NP
I-Cell	990	997	somatic	somatic	JJ	I-NP
I-Cell	998	1003	cells	cell	NNS	I-NP
O	1004	1008	that	that	WDT	B-NP
O	1009	1012	was	be	VBD	B-VP
O	1013	1020	similar	similar	JJ	B-ADJP
O	1021	1023	to	to	TO	B-PP
B-Cancer	1024	1033	neoplasia	neoplasia	NN	B-NP
O	1034	1042	observed	observe	VBN	B-VP
O	1043	1045	in	in	IN	B-PP
O	1046	1052	ageing	age	VBG	B-VP
O	1053	1057	dead	dead	JJ	B-NP
O	1058	1061	end	end	NN	I-NP
O	1062	1063	(	(	(	O
O	1063	1066	dnd	dnd	NN	B-NP
O	1066	1067	)	)	)	O
O	1067	1068	-	-	HYPH	B-NP
O	1068	1077	knockdown	knockdown	JJ	I-NP
O	1078	1083	males	male	NNS	I-NP
O	1083	1084	,	,	,	O
O	1085	1090	which	which	WDT	B-NP
O	1091	1095	lack	lack	VBP	B-VP
B-Cell	1096	1100	germ	germ	NN	B-NP
I-Cell	1101	1106	cells	cell	NNS	I-NP
O	1106	1107	.	.	.	O

O	1108	1111	The	The	DT	B-NP
O	1112	1124	construction	construction	NN	I-NP
O	1125	1127	of	of	IN	B-PP
O	1128	1135	animals	animal	NNS	B-NP
O	1136	1142	doubly	doubly	RB	B-ADJP
O	1143	1149	mutant	mutant	JJ	I-ADJP
O	1150	1153	for	for	IN	B-PP
O	1154	1159	brca2	brca2	NN	B-NP
O	1160	1163	and	and	CC	O
O	1164	1167	the	the	DT	B-NP
O	1168	1177	apoptotic	apoptotic	JJ	I-NP
O	1178	1182	gene	gene	NN	I-NP
O	1183	1187	tp53	tp53	NN	I-NP
O	1188	1189	(	(	(	O
O	1189	1192	p53	p53	NN	B-NP
O	1192	1193	)	)	)	O
O	1194	1201	rescued	rescue	VBD	B-VP
O	1202	1207	brca2	brca2	NN	B-NP
O	1207	1208	-	-	HYPH	B-NP
O	1208	1217	dependent	dependent	JJ	I-NP
O	1218	1221	sex	sex	NN	I-NP
O	1222	1230	reversal	reversal	NN	I-NP
O	1230	1231	.	.	.	O

O	1232	1238	Double	Double	JJ	B-NP
O	1239	1246	mutants	mutant	NNS	I-NP
O	1247	1256	developed	develop	VBD	B-VP
B-Cell	1257	1264	oocytes	oocyte	NNS	B-NP
O	1265	1268	and	and	CC	O
O	1269	1275	became	become	VBD	B-VP
O	1276	1283	sterile	sterile	JJ	B-NP
O	1284	1291	females	female	NNS	I-NP
O	1292	1296	that	that	WDT	B-NP
O	1297	1305	produced	produce	VBD	B-VP
O	1306	1310	only	only	RB	B-NP
O	1311	1319	aberrant	aberrant	JJ	I-NP
B-Developing_anatomical_structure	1320	1327	embryos	embryo	NNS	I-NP
O	1328	1331	and	and	CC	O
O	1332	1338	showed	show	VBD	B-VP
O	1339	1347	elevated	elevated	JJ	B-NP
O	1348	1352	risk	risk	NN	I-NP
O	1353	1356	for	for	IN	B-PP
B-Cancer	1357	1365	invasive	invasive	JJ	B-NP
I-Cancer	1366	1373	ovarian	ovarian	JJ	I-NP
I-Cancer	1374	1380	tumors	tumor	NNS	I-NP
O	1380	1381	.	.	.	O

B-Cell	1382	1389	Oocytes	Oocyte	NNS	B-NP
O	1390	1392	in	in	IN	B-PP
O	1393	1399	double	double	JJ	B-NP
O	1399	1400	-	-	HYPH	I-NP
O	1400	1406	mutant	mutant	JJ	I-NP
O	1407	1414	females	female	NNS	I-NP
O	1415	1421	showed	show	VBD	B-VP
O	1422	1428	normal	normal	JJ	B-NP
O	1429	1441	localization	localization	NN	I-NP
O	1442	1444	of	of	IN	B-PP
O	1445	1450	brca2	brca2	NN	B-NP
O	1451	1454	and	and	CC	I-NP
O	1455	1461	pou5f1	pou5f1	NN	I-NP
O	1462	1473	transcripts	transcript	NNS	I-NP
O	1474	1476	to	to	TO	B-PP
O	1477	1480	the	the	DT	B-NP
B-Cellular_component	1481	1487	animal	animal	NN	I-NP
I-Cellular_component	1488	1492	pole	pole	NN	I-NP
O	1493	1496	and	and	CC	I-NP
O	1497	1501	vasa	vasa	NN	I-NP
O	1502	1513	transcripts	transcript	NNS	I-NP
O	1514	1516	to	to	TO	B-PP
O	1517	1520	the	the	DT	B-NP
B-Cellular_component	1521	1528	vegetal	vegetal	JJ	I-NP
I-Cellular_component	1529	1533	pole	pole	NN	I-NP
O	1533	1534	,	,	,	O
O	1535	1538	but	but	CC	O
O	1539	1542	had	have	VBD	B-VP
O	1543	1544	a	a	DT	B-NP
O	1545	1554	polarized	polarize	VBN	I-NP
O	1555	1561	rather	rather	RB	B-PP
O	1562	1566	than	than	IN	I-PP
O	1567	1578	symmetrical	symmetrical	JJ	B-NP
B-Cellular_component	1579	1586	nucleus	nucleus	NN	I-NP
O	1587	1591	with	with	IN	B-PP
O	1592	1595	the	the	DT	B-NP
O	1596	1608	distribution	distribution	NN	I-NP
O	1609	1611	of	of	IN	B-PP
B-Cellular_component	1612	1620	nucleoli	nucleolus	NNS	B-NP
O	1621	1624	and	and	CC	I-NP
B-Cellular_component	1625	1636	chromosomes	chromosome	NNS	I-NP
O	1637	1639	to	to	TO	B-PP
O	1640	1648	opposite	opposite	JJ	B-NP
B-Cellular_component	1649	1656	nuclear	nuclear	JJ	I-NP
I-Cellular_component	1657	1662	poles	pole	NNS	I-NP
O	1662	1663	;	;	:	O
O	1664	1668	this	this	DT	B-NP
O	1669	1675	result	result	NN	I-NP
O	1676	1684	revealed	reveal	VBD	B-VP
O	1685	1686	a	a	DT	B-NP
O	1687	1692	novel	novel	JJ	I-NP
O	1693	1697	role	role	NN	I-NP
O	1698	1701	for	for	IN	B-PP
O	1702	1707	Brca2	Brca2	NN	B-NP
O	1708	1710	in	in	IN	B-PP
O	1711	1723	establishing	establish	VBG	B-VP
O	1724	1726	or	or	CC	I-VP
O	1727	1738	maintaining	maintain	VBG	I-VP
B-Cellular_component	1739	1745	oocyte	oocyte	NN	B-NP
I-Cellular_component	1746	1753	nuclear	nuclear	JJ	I-NP
O	1754	1766	architecture	architecture	NN	I-NP
O	1766	1767	.	.	.	O

O	1768	1776	Mutating	Mutate	VBG	B-VP
O	1777	1781	tp53	tp53	NN	B-NP
O	1782	1785	did	do	VBD	B-VP
O	1786	1789	not	not	RB	I-VP
O	1790	1796	rescue	rescue	VB	I-VP
O	1797	1800	the	the	DT	B-NP
O	1801	1812	infertility	infertility	NN	I-NP
O	1813	1822	phenotype	phenotype	NN	I-NP
O	1823	1825	in	in	IN	B-PP
O	1826	1831	brca2	brca2	NN	B-NP
O	1832	1838	mutant	mutant	JJ	I-NP
O	1839	1844	males	male	NNS	I-NP
O	1844	1845	,	,	,	O
O	1846	1856	suggesting	suggest	VBG	B-VP
O	1857	1861	that	that	IN	B-SBAR
O	1862	1867	brca2	brca2	NN	B-NP
O	1868	1873	plays	play	VBZ	B-VP
O	1874	1876	an	an	DT	B-NP
O	1877	1886	essential	essential	JJ	I-NP
O	1887	1891	role	role	NN	I-NP
O	1892	1894	in	in	IN	B-PP
O	1895	1904	zebrafish	zebrafish	NN	B-NP
O	1905	1920	spermatogenesis	spermatogenesis	NN	I-NP
O	1920	1921	.	.	.	O

O	1922	1929	Overall	Overall	RB	B-ADVP
O	1929	1930	,	,	,	O
O	1931	1935	this	this	DT	B-NP
O	1936	1940	work	work	NN	I-NP
O	1941	1949	verified	verify	VBD	B-VP
O	1950	1959	zebrafish	zebrafish	NN	B-NP
O	1960	1962	as	as	IN	B-PP
O	1963	1964	a	a	DT	B-NP
O	1965	1970	model	model	NN	I-NP
O	1971	1974	for	for	IN	B-PP
O	1975	1978	the	the	DT	B-NP
O	1979	1983	role	role	NN	I-NP
O	1984	1986	of	of	IN	B-PP
O	1987	1992	Brca2	Brca2	NN	B-NP
O	1993	1995	in	in	IN	B-PP
O	1996	2001	human	human	JJ	B-NP
O	2002	2009	disease	disease	NN	I-NP
O	2010	2013	and	and	CC	O
O	2014	2023	uncovered	uncover	VBD	B-VP
O	2024	2025	a	a	DT	B-NP
O	2026	2031	novel	novel	JJ	I-NP
O	2032	2040	function	function	NN	I-NP
O	2041	2043	of	of	IN	B-PP
O	2044	2049	Brca2	Brca2	NN	B-NP
O	2050	2052	in	in	IN	B-PP
O	2053	2063	vertebrate	vertebrate	NN	B-NP
B-Cellular_component	2064	2070	oocyte	oocyte	NN	I-NP
I-Cellular_component	2071	2078	nuclear	nuclear	JJ	I-NP
O	2079	2091	architecture	architecture	NN	I-NP
O	2091	2092	.	.	.	O

